MCR: modern colistin resistance

I Caniaux1, A van Belkum2, G Zambardi2

  • 1Medical Affairs, bioMérieux SA, 376, Chemin de l'Orme, 69280, Marcy L'Etoile, France.

Insights

Transferable polymyxin resistance in bacteria is emerging in humans and animals, threatening the effectiveness of last-resort antibiotics like colistin. Timely detection through diagnostics is crucial to combat this growing threat.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Plasmid-mediated, transferable polymyxin resistance has been identified in bacterial strains from human and animal sources.
  • This resistance mechanism poses a significant threat of geographic spread and inter-species transmission.
  • The rise of colistin resistance, particularly in Gram-negative carbapenemase producers, could lead to pan-antibiotic resistance, rendering critical treatments ineffective.

Purpose of the Study:

  • To analyze the medical and diagnostic implications of emerging colistin resistance.
  • To propose effective diagnostic strategies for the early detection of colistin resistance in both asymptomatic carriers and infected individuals.

Main Methods:

  • Review and analysis of current medical and diagnostic challenges posed by colistin resistance.
  • Discussion of culture-based diagnostic methods, including chromogenic and selective media for screening clinical and veterinary specimens.
  • Evaluation of relevant molecular diagnostic tests for detecting colistin resistance.

Main Results:

  • Emerging transferable colistin resistance presents a serious global health risk, potentially compromising the efficacy of polymyxin antibiotics.
  • Current diagnostic approaches need enhancement to effectively identify and manage colistin-resistant bacterial infections and carriage.
  • Culture-based and molecular tests are vital for timely detection and surveillance.

Conclusions:

  • Urgent development and implementation of adequate diagnostic tools are necessary to combat the spread of colistin resistance.
  • Effective diagnostics will aid in managing infections caused by resistant bacteria and preventing the loss of polymyxin efficacy.
  • A multi-faceted approach combining culture-based and molecular methods is recommended for comprehensive detection.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.8K
Antibiotic Selection00:57

Antibiotic Selection

Overview
61.8K
Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
434
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
1.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.3K